(AGENPARL) – STRASBURGO gio 13 aprile 2023 AMENDMENTS 011-014REPORTon general guidelines for the preparation of the 2024 budget, Section III…
Browsing: section
(AGENPARL) – STRASBURGO gio 13 aprile 2023 AMENDMENTS 015-018REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – STRASBURGO gio 13 aprile 2023 AMENDMENTS 001-009REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – STRASBURGO mer 12 aprile 2023 AMENDMENTS 030-032REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – STRASBURGO mer 12 aprile 2023 AMENDMENTS 021-028REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – STRASBURGO mer 12 aprile 2023 AMENDMENTS 029-029REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – STRASBURGO mer 12 aprile 2023 AMENDMENTS 019-020REPORTon general guidelines for the preparation of the 2024 budget, Section III…
(AGENPARL) – SILVER SPRING mer 12 aprile 2023 This guidance describes the Food and Drug Administration’s (FDA or the Agency) regulatory…
(AGENPARL) – WASHINGTON sab 08 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…
(AGENPARL) – SILVER SPRING ven 07 aprile 2023 Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C…